Taken together our findings suggest that CD19 SE5-6 isoform responsible for the loss of canonical CD19 epitope, is already present in pediatric B-ALL patients across different subtypes, at the time of diagnosis itself, prior to any therapeutic intervention. This evidence concerns the gene CD19 and precursor B-cell acute lymphoblastic leukemia.